Overview
- Brady and Colossal state that Junie is a genetic copy of the late family dog Lua, created from a pre‑mortem blood sample using a non‑invasive process.
- Colossal Biosciences announced on November 4 that it acquired Viagen Pets & Equine, a long‑running provider of pet‑cloning services.
- Brady is an investor in Colossal, and the statements credit combined Colossal–Viagen technology for producing the clone.
- Experts cited in coverage emphasize that cloning yields a genetic twin rather than restoring the original animal’s personality or experiences.
- Animal‑welfare groups including PETA criticize pet cloning and urge adoption instead, while regulations differ internationally with countries such as Germany restricting such procedures.